首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1735430

非處方藥、維生素和膳食補充劑的全球市場

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

出版日期: 2025年05月13日 | 出版商:

BCC Research | 英文 155 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球非處方藥、維生素和膳食補充劑市場預計將從2025年的2,769億美元成長到2030年底的3,717億美元，2025年至2030年的年複合成長率為 6.1%。

預計亞太市場規模將從2025年的1,202億美元成長到2030年底的1,723億美元，同期的年複合成長率為 7.5%。

預計北美市場規模將從2025年的753億美元成長到2030年底的937億美元，同期的年複合成長率為 4.5%。

本報告調查了全球非處方藥、維生素和營養補充劑市場，並提供了市場的全面概述、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

市場促進因素
自我護理和預防保健的趨勢日益增強
人口結構變化導致的老化
公共衛生系統壓力日益增大
優質化和創新推動定價
線上銷售管道增加和遠端醫療平台成長
市場限制
自有品牌的可用性和接受度不斷提高
替代品的威脅
替代方案的存在
季節性影響
市場機會
新興國家中產階級的擴大
女性對健康和認知支持產品的需求不斷增加
轉向草藥和有機產品
電子商務與直接面對消費者
關鍵要點

第4章監管情況

美國
非處方藥
維生素和營養補充劑
歐洲
非處方藥
維生素和營養補充劑
亞太地區
非處方藥
維生素和營養補充劑

第5章新興技術與發展

意識提升
透過創新延伸品牌
從處方藥轉為非處方藥

第6章市場區隔分析

細分市場
非處方藥、維生素和營養補充劑市場（依產品類型）
維生素和營養補充劑
市場概覽
關鍵要點
市場收益和預測
維生素和營養補充品市場（依銷售地點）
零售藥局/商店
電子商務
其他
非處方藥
市場概覽
關鍵要點
依產品類型分類的市場收益和預測
呼吸治療
緩解疼痛
消化器官系統健康
皮膚科藥物
口腔醫學
眼部護理
禁止抽煙
依銷售地點分類的非處方藥市場
零售藥局/商店
網路藥局
地理分佈
非處方藥、維生素和營養補充劑市場（依地區）
關鍵要點
北美洲
歐洲
亞太地區
中東和非洲
南美洲

第7章競爭訊息

關鍵要點
非處方藥
維生素和營養補充劑
主要發展和策略

第8章非處方藥、維生素和膳食補充劑市場的永續性：ESG視角

ESG：簡介
環境
社會
管治
ESG風險評估
結論

第9章附錄

調查方法
來源
簡稱
公司簡介
ABBOTT
AMWAY CORP.
BAYER AG
DSM- FIRMENICH
HALEON GROUP OF CO.
HERBALIFE LTD.
KENVUE
NESTLE HEALTH SCIENCE
OPELLA HEALTHCARE GROUP SAS
PHARMAVITE
PROCTER & GAMBLE
RECKITT
STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
新興Start-Ups/市場顛覆者

簡介目錄圖表

Product Code: PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

The Asia-Pacific market for OTC drugs, vitamins and dietary supplements is expected to grow from $120.2 billion in 2025 and is projected to reach $172.3 billion by the end of 2030, at a CAGR of 7.5% during the forecast period of 2025 to 2030.

The North American market for OTC drugs, vitamins and dietary supplements is expected to grow from $75.3 billion in 2025 and is projected to reach $93.7 billion by the end of 2030, at a CAGR of 4.5% during the forecast period of 2025 to 2030.

Report Scope

This report provides an overview of the global over-the-counter (OTC) drugs, vitamins and dietary supplements market and analyzes trends in this market. It includes global revenue ($ million) for the base year of 2024, estimated market values for 2025, and market values for the forecast period 2025 through 2030. In this report, market revenue refers to ex-factory or ex-manufacturer sales, representing the value of goods as they leave the manufacturer and before any markups by wholesalers or retailers.

The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.

The report concludes with an analysis of the competitive landscape of this market, providing the ranking and share of key players. It also has a company profiles section that is dedicated to providing details about leading market players.

It is important to note that this report's scope covers only pharmacological OTC drugs and excludes any other types of drugs, such as alternative therapies. Also, dietary supplements for weight management, meal replacements, medical nutrition, sports nutrition, and skin care are not included in this report.

Report Includes

46 data tables and 59 additional tables
An overview of the global market for over-the-counter drugs, vitamins and dietary supplements
An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Highlights of the current and future market potential and quantification of the market by product type, point of sales, and geographic region
Discussion on market opportunities for over-the-counter drugs, vitamins and dietary supplement applications, industry structure, and regulatory scenarios
Information on the latest developments in healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Comprehensive company profiles of the leading players of the industry, including Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer AG, and Procter & Gamble

Chapter 1 Executive Summary

Scope of Report
Market Summary

Chapter 2 Market Overview

Market Definitions
Over-the-counter (OTC) Drugs
Vitamins and Dietary Supplements
Industry Overview
Macroeconomic Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers (High)
Bargaining Power of Suppliers (Moderate to Low)
Threat of New Entrants (Moderate)
Threat of Substitutes (Low)
Industry Competition (High)

Chapter 3 Market Dynamics

Market Drivers
Increasing Trend Toward Self-Care and Preventive Care
Changing Demographics Resulting in Aging Population
Increasing Pressure on Public Health Systems
Premiumization and Innovation Driving Pricing
Rising Online Sales Channels and Growth of Telehealth Platforms
Market Restraints
Increases in the Availability and Acceptance of Private-Label Brands
Threat from Counterfeit Products
Presence of Alternative Methods
Impact of Seasonality
Market Opportunities
Growing Middle Class in Emerging Economies
Growing Demand for Women's Health and Cognitive Health Support Products
Shift Toward Herbal and Organic Products
E-Commerce and Direct-to-Consumer Sales
Key Takeaways

Chapter 4 Regulatory Landscape

U.S.
OTC Drugs
Vitamins and Dietary Supplements
Europe
OTC Drugs
Vitamins and Dietary Supplements
Asia-Pacific
OTC Drugs
Vitamins and Dietary Supplements

Chapter 5 Emerging Technologies and Developments

Increased Awareness of Ingredient Labeling
Brand Extension Fueled by Innovation
Rx-to-OTC Switch

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Product Type
Vitamins and Dietary Supplements
Market Overview
Key Takeaways
Market Revenue and Forecast
Vitamins and Dietary Supplements Market, by Point of Sale
Retail Pharmacies and Stores
E-Commerce
Other Points of Sales
OTC Drugs
Market Overview
Key Takeaways
Market Revenue and Forecast, by Product Type
Respiratory Treatments
Pain Relief
Digestive Health
Dermatological Drugs
Oral Medical Care
Eye Care
Smoking Cessation
OTC Drugs Market, by Point of Sale
Retail Pharmacies and Stores
E-Pharmacies
Geographic Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America

Chapter 7 Competitive Intelligence

Key Takeaways
OTC Drugs
Vitamins and Dietary Supplements
Key Developments and Strategies

Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective

Introduction to ESG
Environment
Social
Governance
ESG Risk Ratings
Conclusion

Chapter 9 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AMWAY CORP.
BAYER AG
DSM- FIRMENICH
HALEON GROUP OF CO.
HERBALIFE LTD.
KENVUE
NESTLE HEALTH SCIENCE
OPELLA HEALTHCARE GROUP SAS
PHARMAVITE
PROCTER & GAMBLE
RECKITT
STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Emerging Start-ups/ Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 1 : Benefits of Over-the-Counter (OTC) Drugs
Table 2 : Porter's Five Forces: Rating Scale
Table 3 : Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
Table 4 : Asia-Pacific: Regulatory Landscape
Table 5 : Rx-to-OTC Switch Drugs, 2020-2024*
Table 6 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 7 : Common Dietary Supplements
Table 8 : Specialty Dietary Supplements
Table 9 : Global Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 10 : Global Market for OTC Drugs, by Product Type, Through 2030
Table 11 : Common OTC Respiratory Drugs
Table 12 : Most Common OTC Pain Relievers
Table 13 : Digestive Health OTC Drugs
Table 14 : Most Common OTC Dermatological Drugs
Table 15 : OTC Eye Care Drugs
Table 16 : OTC Smoking Cessation Products
Table 17 : Global Market for OTC Drugs, by Point of Sale, Through 2030
Table 18 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 19 : North American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 20 : North American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 21 : North American Market for OTC Drugs, by Point of Sale, Through 2030
Table 22 : North American Population and GDP Data, by Country, 2023
Table 23 : U.S. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 24 : Canadian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 25 : Mexican Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 26 : European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 27 : European Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 28 : European Market for OTC Drugs, by Point of Sale, Through 2030
Table 29 : German Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 30 : U.K. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 31 : French Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 32 : Italian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 33 : Rest of European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 34 : Asia-Pacific Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 35 : Asia-Pacific Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 36 : Asia-Pacific Market for OTC Drugs, by Point of Sale, Through 2030
Table 37 : Chinese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 38 : Japanese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 39 : Indian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 40 : Rest of APAC Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 41 : Middle Eastern and African Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 42 : Middle Eastern and African Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 43 : Middle Eastern and African Market for OTC Drugs, by Point of Sale, Through 2030
Table 44 : South American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 45 : South American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 46 : South American Market for OTC Drugs, by Point of Sale, Through 2030
Table 47 : OTC Drugs: Market Player Share Analysis, 2024
Table 48 : Leading Vitamin and Dietary Supplement Companies and Their Key Brands, 2024
Table 49 : Key Developments and Strategies, 2023-2025
Table 50 : ESG Pillars for OTC Drugs, Vitamins and Dietary Supplements Market
Table 51 : ESG Risk Rankings for OTC Drugs, Vitamins and Dietary Supplements Companies, 2025*
Table 52 : Report Sources
Table 53 : Abbreviations Used in This Report
Table 54 : Abbott: Company Snapshot
Table 55 : Abbott: Financial Performance, FY 2023 and 2024
Table 56 : Abbott: Product Portfolio
Table 57 : Amway Corp.: Company Snapshot
Table 58 : Amway Corp.: Product Portfolio
Table 59 : Bayer AG: Company Snapshot
Table 60 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 61 : Bayer AG: Product Portfolio
Table 62 : Bayer AG: News/Key Developments, 2024 and 2025
Table 63 : DSM-Firmenich: Company Snapshot
Table 64 : DSM-Firmenich: Financial Performance, FY 2023 and 2024
Table 65 : DSM-Firmenich: Product Portfolio
Table 66 : DSM-Firmenich: News/Key Developments, 2023 and 2024
Table 67 : Haleon Group of Co.: Company Snapshot
Table 68 : Haleon Group of Co.: Financial Performance, FY 2023 and 2024
Table 69 : Haleon Group of Co.: Product Portfolio
Table 70 : Haleon Group of Co.: News/Key Developments, 2023
Table 71 : Herbalife Ltd.: Company Snapshot
Table 72 : Herbalife Ltd.: Financial Performance, FY 2023 and 2024
Table 73 : Herbalife Ltd.: Product Portfolio
Table 74 : Herbalife Ltd.: News/Key Developments, 2023
Table 75 : Kenvue: Company Snapshot
Table 76 : Kenvue: Financial Performance, FY 2023 and 2024
Table 77 : Kenvue: Product Portfolio
Table 78 : Kenvue: News/Key Developments, 2023
Table 79 : Nestle Health Science: Company Snapshot
Table 80 : Nestle Health Science: Financial Performance, FY 2023 and 2024
Table 81 : Nestle Health Science: Product Portfolio
Table 82 : Opella Healthcare Group SAS: Company Snapshot
Table 83 : Opella Healthcare Group SAS: Product Portfolio
Table 84 : Opella Healthcare Group SAS: News/Key Developments, 2023-2025
Table 85 : Pharmavite: Company Snapshot
Table 86 : Pharmavite: Product Portfolio
Table 87 : Pharmavite: News/Key Developments, 2023 and 2024
Table 88 : Procter & Gamble: Company Snapshot
Table 89 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 90 : Procter & Gamble: Product Portfolio
Table 91 : Reckitt: Company Snapshot
Table 92 : Reckitt: Financial Performance, FY 2023 and 2024
Table 93 : Reckitt: Product Portfolio
Table 94 : Reckitt: News/Key Developments, 2024
Table 95 : Stada Arzneimittel AG: Company Snapshot
Table 96 : Stada Arzneimittel AG: Financial Performance, FY 2022 and 2023
Table 97 : Stada Arzneimittel AG: Product Portfolio
Table 98 : Stada Arzneimittel AG: News/Key Developments, 2023 and 2024
Table 99 : Taisho Pharmaceutical Holdings Co. Ltd.: Company Snapshot
Table 100 : Taisho Pharmaceutical Holdings Co. Ltd.: Product Portfolio
Table 101 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 102 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2023 and 2024
Table 103 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 104 : List of Few Emerging Startups/ Market Disruptors

List of Figures

Summary Figure : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 1 : Porter's Five Forces Analysis
Figure 2 : Market Dynamics Snapshot
Figure 3 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 4 : Global Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 5 : Global Market Shares of OTC Drugs, by Product Type, 2024
Figure 6 : Global Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 7 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 8 : North American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 9 : North American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 10 : North American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 11 : U.S. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 12 : Canadian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 13 : Mexican Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 14 : European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 15 : European Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 16 : European Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 17 : German Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 18 : U.K. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 19 : French Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 20 : Italian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 21 : Rest of European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 22 : Asia-Pacific Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 23 : Asia-Pacific Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 24 : Asia-Pacific Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 25 : Chinese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 26 : Japanese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 27 : Indian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 28 : Rest of APAC Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 29 : Middle Eastern and African Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 30 : Middle Eastern and African Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 31 : Middle Eastern and African Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 32 : South American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 33 : South American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 34 : South American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 35 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 37 : Bayer AG: Revenue Shares, by Business Unit, FY 2024
Figure 38 : Bayer AG: Revenue Shares, by Country/Region, FY 2024
Figure 39 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2024
Figure 40 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2024
Figure 41 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2024
Figure 42 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2024
Figure 43 : Herbalife Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 44 : Herbalife Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 45 : Kenvue: Revenue Shares, by Business Unit, FY 2024
Figure 46 : Kenvue: Revenue Shares, by Country/Region, FY 2024
Figure 47 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 48 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 49 : Reckitt: Revenue Shares, by Business Unit, FY 2024
Figure 50 : Reckitt: Revenue Shares, by Country/ Region, FY 2024
Figure 51 : Stada Arzneimittel AG: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Stada Arzneimittel AG: Revenue Shares, by Country/ Region, FY 2023
Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Shares, by Business Unit, 2024